314 related articles for article (PubMed ID: 25290419)
1. Nanoparticle based-immunotherapy against allergy.
Gamazo C; Gastaminza G; Ferrer M; Sanz ML; Irache JM
Immunotherapy; 2014; 6(7):885-97. PubMed ID: 25290419
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in allergen immunotherapy.
Nouri-Aria KT
Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
[TBL] [Abstract][Full Text] [Related]
3. [Applicable strategies for the mucosal immune system in the regulation of allergic diseases].
Kurashima Y; Kunisawa J; Kiyono H
Arerugi; 2008 Feb; 57(2):87-94. PubMed ID: 18349582
[No Abstract] [Full Text] [Related]
4. Allergen-specific immunotherapy.
Nelson HS; Norman PS
Chem Immunol Allergy; 2014; 100():333-8. PubMed ID: 24925414
[TBL] [Abstract][Full Text] [Related]
5. Allergen-specific T lymphocytes as targets for specific immunotherapy: striking at the roots of type I allergy.
Bohle B
Arch Immunol Ther Exp (Warsz); 2002; 50(4):233-41. PubMed ID: 12371619
[TBL] [Abstract][Full Text] [Related]
6. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
Mutschlechner S; Deifl S; Bohle B
Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
Virkud YV; Wang J; Shreffler WG
Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses.
Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF
Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083
[TBL] [Abstract][Full Text] [Related]
9. [The immunological mechanisms contributing to the clinical efficacy of allergen specific immunotherapy (SIT) in allergic diseases].
Asher I; Mahlab-Guri K; Sthoeger Z
Harefuah; 2013 Sep; 152(9):529-33, 564, 563. PubMed ID: 24364093
[TBL] [Abstract][Full Text] [Related]
10. [DNA vaccines against allergy].
Sato Y; Kasukawa R
Nihon Rinsho; 2000 Jun; 58(6):1307-14. PubMed ID: 10879058
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Immune Responses in Food Immunotherapy.
Smeekens JM; Kulis MD
Immunol Allergy Clin North Am; 2020 Feb; 40(1):87-95. PubMed ID: 31761123
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
13. Renaissance of the blocking antibody concept in type I allergy.
Flicker S; Valenta R
Int Arch Allergy Immunol; 2003 Sep; 132(1):13-24. PubMed ID: 14555854
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis and immunotherapy.
Sastre J
Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):646-50. PubMed ID: 24071714
[TBL] [Abstract][Full Text] [Related]
15. A DNA vaccine encoding a chimeric allergen derived from major group 1 allergens of dust mite can be used for specific immunotherapy.
Sun T; Yin K; Wu LY; Jin WJ; Li Y; Sheng B; Jiang YX
Int J Clin Exp Pathol; 2014; 7(9):5473-83. PubMed ID: 25337189
[TBL] [Abstract][Full Text] [Related]
16. Allergic inflammation and the oral mucosa.
Incorvaia C; Frati F; Sensi L; Riario-Sforza GG; Marcucci F
Recent Pat Inflamm Allergy Drug Discov; 2007 Feb; 1(1):35-8. PubMed ID: 19075964
[TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
Hessel EM; Chu M; Lizcano JO; Chang B; Herman N; Kell SA; Wills-Karp M; Coffman RL
J Exp Med; 2005 Dec; 202(11):1563-73. PubMed ID: 16314434
[TBL] [Abstract][Full Text] [Related]
18. Regulatory cells in allergen-specific immunotherapy.
Soyka MB; Holzmann D; Akdis CA
Immunotherapy; 2012 Apr; 4(4):389-96. PubMed ID: 22512633
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy.
Scott-Taylor TH; Axinia SC; Amin S; Pettengell R
Immun Inflamm Dis; 2018 Mar; 6(1):13-33. PubMed ID: 29164823
[TBL] [Abstract][Full Text] [Related]
20. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
